Recap: ADC Therapeutics Q4 Earnings

ADC Therapeutics ADCT reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

ADC Therapeutics beat estimated earnings by 54.65%, reporting an EPS of $-0.39 versus an estimate of $-0.86.

Revenue was up $17.01 million from the same period last year.

Last quarter the company beat on EPS by $0.33 which was followed by a 3.32% increase in the share price the next day.

Here's a look at ADC Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.92	-0.82	-0.90	-0.38
EPS Actual	-0.59	-0.70	-0.74	-0.82
Revenue Estimate	7.39M	2.37M	90.00K	860.00K
Revenue Actual	13.15M	3.76M	0	0

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar